MONTREAL, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage ...
Montréal, Canada - November 11, 2010 - Theratechnologies (TSX: TH) announced today that the U.S. Food and Drug Administration ("FDA") has approved EGRIFTATM (tesamorelin for injection) as the first ...
There were 259 subjects included in this study, including 122 children/adolescents and 137 adults (Table 1). The detailed demographic data are shown in Table 1. Skin thickness varied minimally with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback